Akers Biosciences, Inc. Announces Pricing Of Public Offering Of Common Stock And Listing On NASDAQ

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

THOROFARE, N.J., Jan. 23, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "Akers Biosciences), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announced the pricing of an underwritten public offering of 2,727,000 shares (the "Shares") of common stock at a public offering price of $5.50 per share. The shares will begin trading on The NASDAQ Capital Market on January 23, 2014 at approximately 2:10 PM EST under the symbol "AKER." The Company expects to receive approximately $15,000,000 in gross proceeds, before underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the representative of the underwriters a 45-day option to purchase up to 409,050 additional shares of common stock.

Help employers find you! Check out all the jobs and post your resume.

Back to news